The purpose of this panel discussion, which concluded the Tuesday BPI Theater sessions at BIO, was to introduce a new eBook, How to Jump Five Unforeseen Hurdles in Biotech Success, edited by Lisa LaMotta. Other contributors to the eBook — Ramani Varanasi (X-Biotix Therapeutics), Chris Haskell (Bayer Healthcare), Dan Geffken (Danforth Advisors), Luba Greenwood (Google’s Verily), Ailis Tweed-Kent (Cocoon Biotech), and Teresa Lavoie (Fish & Richardson) — joined LaMotta on this panel to explore ways of building an intellectual property (IP) portfolio, choosing a board of directors, and developing a partnering pitch.
Watch the full roundtable discussion below and leave your thoughts or questions on the topic below in the comments.
ScaleReady and Germfree discuss the need to rethink sustainability and move towards a more standardized and simplistic manufacturing model to ensure health equity can be achieved.
The European Cell and Gene Therapy Congress for Groundbreaking Manufacturing, Commercialisation & Analytical Strategies: World renowned leaders share the latest process development, analytical and market access strategies to improve manufacturing scalability, quality and cost to propel your CGT programmes to commercial success